« Previous
Next »
American Journal of Cardiology
Volume 104, Issue 6
, Pages 846-849
, 15 September 2009
Effect of Balloon Valvuloplasty in Patients With Severe Aortic Stenosis on Levels of N-Terminal Pro-B-Type Natriuretic Peptide
References
- . Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease. Eur Heart J. 2005;26:1023–1030
- . Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis. Circulation. 2003;107:1884–1890
- . Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation. 2004;109:2302–2308
- . The effect of aortic valve replacement on plasma B-type natriuretic peptide in patients with severe aortic stenosis—one year follow-up. Eur J Heart Fail. 2006;8:257–262
- . ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation. 2006;114:e84–e231
- . Rapid pacing to facilitate transcatheter prosthetic heart valve implantation. Catheter Cardiovasc Interv. 2006;68:199–204
- . Long-term mortality, cause of death, and temporal trends in complications after percutaneous aortic balloon valvuloplasty for calcific aortic stenosis. J Interv Cardiol. 2006;19:269–275
- . Current results of balloon aortic valvuloplasty in high-risk patients. J Invasive Cardiol. 2007;19:1–5
- . Feasibility of transcatheter intervention for severe aortic stenosis in patients ≥90 years of age: aortic valvuloplasty revisited. Catheter Cardiovasc Interv. 2007;70:149–154
- . Measurement and significance of circulating natriuretic peptides in cardiovascular disease. Clin Sci. 1998;95:519–529
- . Essential biochemistry and physiology of (NT-pro)BNP. Eur J Heart Fail. 2004;6:257–260
- . Plasma levels of brain and atrial natriuretic peptides elevate in proportion to left ventricular end-systolic wall stress in patients with aortic stenosis. Am Heart J. 1997;133:307–314
- . Transcardiac gradients of N-terminal B-type natriuretic peptide in aortic valve stenosis. Eur J Heart Fail. 2005;7:809–814
- . B-type natriuretic peptide in low-flow, low-gradient aortic stenosis (Relationship to hemodynamics and clinical outcome: results from the Multicenter Truly or Pseudo-Severe Aortic Stenosis (TOPAS) study). Circulation. 2007;115:2848–2855
- . Percutaneous balloon aortic valvuloplasty revisited: time for a renaissance?. Circulation. 2007;115:334–338
- . Contemporary surgical or percutaneous management of severe aortic stenosis in the elderly. Eur Heart J. 2008;29:1410–1417
- . Aortic valve replacement in adults after balloon aortic valvuloplasty. Circulation. 1994;90:II205–II208
- . Results of repeat balloon valvuloplasty for treatment of aortic stenosis in patients aged 59 to 104 years. Am J Cardiol. 2005;95:43–47
PII: S0002-9149(09)01048-0
doi: 10.1016/j.amjcard.2009.05.013
© 2009 Elsevier Inc. All rights reserved.
« Previous
Next »
American Journal of Cardiology
Volume 104, Issue 6
, Pages 846-849
, 15 September 2009
